BriaCell Therapeutics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024
March 18, 2024 at 05:16 pm EDT
BriaCell Therapeutics Corp. reported earnings results for the second quarter and six months ended January 31, 2024. For the second quarter, the company reported net loss was USD 11.29 million compared to USD 11.88 million a year ago. Basic loss per share from continuing operations was USD 0.71 compared to USD 0.77 a year ago. Diluted loss per share from continuing operations was USD 0.71 compared to USD 0.77 a year ago.
For the six months, net loss was USD 5.29 million compared to USD 12.99 million a year ago. Basic loss per share from continuing operations was USD 0.33 compared to USD 0.84 a year ago. Diluted loss per share from continuing operations was USD 0.33 compared to USD 0.84 a year ago.